Chemical Structure (Sumatriptan 01)
Sumatriptan Injection
Product Images NDC 70594-068
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 70594-068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Sumatriptan 02)
The text shows a chart indicating the estimated percentage of patients experiencing relief from a placebo and sumatriptan over time, with intervals of 20, 40, 60, 80, and 100. The data included the number of patients for each treatment (placebo and sumatriptan).*
Principal Display Panel (6 mg/0.5 mL Vial Carton)
This is a product description for Sumatriptan Injection USP, which comes in 5 single-dose vials with a concentration of 6 mg/0.5 mL for subcutaneous injection only. Each 0.5 mL of solution contains 8.4 mg of sumatriptan succinate equivalent to 6 mg of sumatriptan and 3.5 mg of sodium chloride. The manufacturer is Xellia Pharmaceuticals USA, LLC, and the product is made in India. The solution is sterile and non-pyrogenic, and the unused portion should be discarded. The prescribing information should be consulted for proper dosage information. The product should be stored between 2° and 30°C and protected from light. An unvarnished area is available for batch overprinting of 2D code, Sr. No, GTIN, Lot number, and Exp date details during online packing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
